Susquehanna International Group
XPH icon

Susquehanna International Group’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

Susquehanna International Group’s Portfolio XPH Stock Details XPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-21,500
Closed -$1.2M – 14248
2025
Q4 		$1.2M Sell
21,500
-700
-3% -$36.3K ﹤0.01% 6768
2025
Q3 		$1.06M Sell
22,200
-5,500
-20% -$246K ﹤0.01% 7218
2025
Q2 		$1.12M Buy
27,700
+3,800
+16% +$153K ﹤0.01% 7136
2025
Q1 		$1.05M Buy
23,900
+900
+4% +$39.7K ﹤0.01% 7148
2024
Q4 		$989K Buy
23,000
+2,500
+12% +$114K ﹤0.01% 6966
2024
Q3 		$909K Sell
20,500
-400
-2% -$17.1K ﹤0.01% 7002
2024
Q2 		$831K Buy
20,900
+9,600
+85% +$389K ﹤0.01% 7022
2024
Q1 		$487K Buy
11,300
+500
+5% +$21.5K ﹤0.01% 8580
2023
Q4 		$449K Sell
10,800
-9,900
-48% -$375K ﹤0.01% 8937
2023
Q3 		$823K Sell
20,700
-1,300
-6% -$55K ﹤0.01% 7081
2023
Q2 		$902K Buy
22,000
+900
+4% +$37.2K ﹤0.01% 6925
2023
Q1 		$865K Sell
21,100
-4,100
-16% -$172K ﹤0.01% 7197
2022
Q4 		$1.03M Buy
25,200
+2,000
+9% +$83.3K ﹤0.01% 6115
2022
Q3 		$932K Buy
23,200
+2,900
+14% +$124K ﹤0.01% 6808
2022
Q2 		$853K Buy
20,300
+3,600
+22% +$151K ﹤0.01% 6914
2022
Q1 		$756K Sell
16,700
-2,200
-12% -$96.7K ﹤0.01% 7866
2021
Q4 		$872K Buy
+18,900
New +$895K ﹤0.01% 7647
2020
Q3 		– Sell
-7,800
Closed -$335K – 11241
2020
Q2 		$335K Buy
7,800
+2,200
+39% +$90.9K ﹤0.01% 8166
2020
Q1 		$202K Buy
+5,600
New +$239K ﹤0.01% 8680
2018
Q3 		– Sell
-5,600
Closed -$241K – 10377
2018
Q2 		$241K Hold
5,600
– – ﹤0.01% 8261
2018
Q1 		$234K Buy
+5,600
New +$244K ﹤0.01% 8066
2017
Q1 		– Sell
-11,000
Closed -$430K – 10124
2016
Q4 		$430K Buy
11,000
+3,500
+47% +$142K ﹤0.01% 7298
2016
Q3 		$331K Buy
+7,500
New +$341K ﹤0.01% 6769
2016
Q1 		– Sell
-4,100
Closed -$210K – 9762
2015
Q4 		$210K Sell
4,100
-700
-15% -$35.7K ﹤0.01% 8347
2015
Q3 		$225K Sell
4,800
-3,400
-41% -$205K ﹤0.01% 8528
2015
Q2 		$511K Sell
8,200
-2,800
-25% -$174K ﹤0.01% 7606
2015
Q1 		$679K Buy
+11,000
New +$652K ﹤0.01% 6551
2014
Q4 		– Sell
-8,000
Closed -$424K – 10171
2014
Q3 		$424K Buy
+8,000
New +$407K ﹤0.01% 7490

Other funds holding XPH

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Carson Wealth (CWM LLC)
Carson Wealth (CWM LLC) Omaha, Nebraska $38.1B AUM 19.66% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
KWM
Kingsview Wealth Management Grants Pass, Oregon $7.33B AUM 16.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
FCBT
First Citizens Bank & Trust Raleigh, North Carolina $6.69B AUM 24.48% 1-Year Est. Return
Envestnet Portfolio Solutions
Envestnet Portfolio Solutions Chicago, Illinois $18.1B AUM 15% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $74.2B AUM 21.09% 1-Year Est. Return

Susquehanna International Group's XPH Position: Q1 2026 in Review

Susquehanna International Group increased its State Street SPDR S&P Pharmaceuticals ETF (XPH) stake by 127% in Q1 2026, buying an estimated $1.52M and bringing the position to 48,834 shares worth $2.64M. The position accounts for ﹤0.01% of the portfolio, ranked #5543.

Susquehanna International Group first reported a position in XPH in Q2 2013 and has held it in 47 quarters since. The position peaked at $19.2M in Q3 2015. 82 funds tracked by Wall St. Rank hold XPH as of Q1 2026.

  • Susquehanna International Group held 48,834 shares of State Street SPDR S&P Pharmaceuticals ETF worth $2.64M as of Q1 2026.
  • Susquehanna International Group bought 27,337 State Street SPDR S&P Pharmaceuticals ETF shares in Q1 2026, an estimated $1.52M.
  • State Street SPDR S&P Pharmaceuticals ETF made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #5543 holding.
  • Susquehanna International Group first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q2 2013 and has held it in 47 quarters since.
  • Susquehanna International Group's State Street SPDR S&P Pharmaceuticals ETF position peaked at $19.2M in Q3 2015.
  • 82 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.